Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin in Amyotrophic Lateral Sclerosis (ACACIA)
NCT07047209Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2025
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin in amyotrophic lateral sclerosis (ALS), sponsored by Massachusetts General Hospital. Started May 2025; status: completed.
02
Drugs
digoxin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT07047209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07047209.